Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Altered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in Gulf War veterans.

O'Donovan A, Chao LL, Paulson J, Samuelson KW, Shigenaga JK, Grunfeld C, Weiner MW, Neylan TC.

Psychoneuroendocrinology. 2015 Jan;51:557-66. doi: 10.1016/j.psyneuen.2014.11.010. Epub 2014 Nov 18.

2.

Are hippocampal size differences in posttraumatic stress disorder mediated by sleep pathology?

Mohlenhoff BS, Chao LL, Buckley ST, Weiner MW, Neylan TC.

Alzheimers Dement. 2014 Jun;10(3 Suppl):S146-54. doi: 10.1016/j.jalz.2014.04.016.

3.

Early adversity and combat exposure interact to influence anterior cingulate cortex volume in combat veterans.

Woodward SH, Kuo JR, Schaer M, Kaloupek DG, Eliez S.

Neuroimage Clin. 2013 May 5;2:670-4. doi: 10.1016/j.nicl.2013.04.016. eCollection 2013.

4.

Deployment and post-deployment experiences in OEF/OIF veterans: relationship to gray matter volume.

Aupperle RL, Connolly CG, Stillman AN, May AC, Paulus MP.

PLoS One. 2013 Sep 18;8(9):e75880. doi: 10.1371/journal.pone.0075880. eCollection 2013.

5.

Individual differences in recovery from traumatic fear.

Holmes A, Singewald N.

Trends Neurosci. 2013 Jan;36(1):23-31. doi: 10.1016/j.tins.2012.11.003. Epub 2012 Dec 19. Review.

6.

Molecular and genetic basis of stress.

Mehić B.

Bosn J Basic Med Sci. 2012 May;12(2):63. No abstract available.

7.

Cortical thinning in patients with recent onset post-traumatic stress disorder after a single prolonged trauma exposure.

Liu Y, Li YJ, Luo EP, Lu HB, Yin H.

PLoS One. 2012;7(6):e39025. doi: 10.1371/journal.pone.0039025. Epub 2012 Jun 13.

8.

Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder.

Norman SB, Myers US, Wilkins KC, Goldsmith AA, Hristova V, Huang Z, McCullough KC, Robinson SK.

Neuropharmacology. 2012 Feb;62(2):542-51. doi: 10.1016/j.neuropharm.2011.04.032. Epub 2011 May 13. Review.

9.

Twin studies of posttraumatic stress disorder: differentiating vulnerability factors from sequelae.

Kremen WS, Koenen KC, Afari N, Lyons MJ.

Neuropharmacology. 2012 Feb;62(2):647-53. doi: 10.1016/j.neuropharm.2011.03.012. Epub 2011 Mar 31. Review.

10.

Structural alterations in lateral prefrontal, parietal and posterior midline regions of men with chronic posttraumatic stress disorder.

Eckart C, Stoppel C, Kaufmann J, Tempelmann C, Hinrichs H, Elbert T, Heinze HJ, Kolassa IT.

J Psychiatry Neurosci. 2011 May;36(3):176-86. doi: 10.1503/jpn.100010.

11.

Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder.

Wang Z, Neylan TC, Mueller SG, Lenoci M, Truran D, Marmar CR, Weiner MW, Schuff N.

Arch Gen Psychiatry. 2010 Mar;67(3):296-303. doi: 10.1001/archgenpsychiatry.2009.205.

12.

Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior.

Cortese BM, Mitchell TR, Galloway MP, Prevost KE, Fang J, Moore GJ, Uhde TW.

Physiol Behav. 2010 Mar 30;99(4):445-50. doi: 10.1016/j.physbeh.2009.12.005. Epub 2009 Dec 13.

13.

Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder.

Schuff N, Neylan TC, Fox-Bosetti S, Lenoci M, Samuelson KW, Studholme C, Kornak J, Marmar CR, Weiner MW.

Psychiatry Res. 2008 Feb 28;162(2):147-57. doi: 10.1016/j.pscychresns.2007.04.011. Epub 2008 Jan 16.

Items per page

Supplemental Content

Write to the Help Desk